InvestorsHub Logo
Followers 99
Posts 2761
Boards Moderated 2
Alias Born 02/10/2004

Re: None

Saturday, 02/28/2015 10:45:02 AM

Saturday, February 28, 2015 10:45:02 AM

Post# of 430
Covalon will begin to market their own Antimicrobial Foley Catheter's as well, which have been marketed by Medline as their Silvertouch Foley catheters since 2006. Medline's product literature makes a good case of the superiority of their product over their competitors: http://www.medline.com/irj/servlet/prt/portal/prtroot/pcd!3aportal_content!2fmedline!2fGlobal!2fPublicDocs/publicdocuments/Medline%20Documents/Marketing%20Materials/MarketingDocuments_N-Z/SIlvertouch%20Brochure%20MKT210104%20LIT498.pdf

Despite the convincing data, this Frost & Sullivan report on the Urinary Incontinence Market shows Medline had only captured 2% of the Antimicrobial Foley Catheter market in 2009 (page 40):
http://www.academia.edu/7673287/U._S._Urinary_Incontinence_Devices

Hopefully Covalon's more focused sales team can improve their market share in this market.

"Our houses are such unwieldy property that we are often imprisoned rather than housed in them." - Henry David Thoreau, Walden: Economy, 1854